Drugs / SCTV04C
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06801509 | Feb → Nov 2025 overdue | herpes zoster | Sinocelltech Ltd. | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SCTV04C | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06801509 ↗ |
| Modality | Vaccine | “Recombinant Herpes Zoster Vaccine” NCT06801509 ↗ |
| Route | Intramuscular | “Route of vaccination: intramuscular injection into the lateral deltoid of the upper arm” NCT06801509 ↗ |